Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ELOVL4 Antikörper

ELOVL4 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN4620376
  • Target Alle ELOVL4 Antikörper anzeigen
    ELOVL4 (ELOVL Fatty Acid Elongase 4 (ELOVL4))
    Reaktivität
    • 41
    • 15
    • 10
    • 5
    • 2
    • 2
    Human
    Wirt
    • 41
    Kaninchen
    Klonalität
    • 41
    Polyklonal
    Konjugat
    • 18
    • 6
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser ELOVL4 Antikörper ist unkonjugiert
    Applikation
    • 31
    • 28
    • 7
    • 4
    • 4
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Spezifität
    This antibody detects ELOV4, expressed in the retina and at much lower level in the brain.
    Aufreinigung
    Affinity chromatography
    Immunogen
    Synthetic peptdide derived from the human ELOV4 protein
    Isotyp
    IgG
    Top Product
    Discover our top product ELOVL4 Primärantikörper
  • Applikationshinweise
    Western Blot (1: 400 starting dilution).
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Buffer
    Phosphate buffered saline with 0.08 % sodium azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store the product (in aliquots) at -20 °C. Can be shipped at 2 - 8 °C.
  • Target
    ELOVL4 (ELOVL Fatty Acid Elongase 4 (ELOVL4))
    Andere Bezeichnung
    ELOVL4 (ELOVL4 Produkte)
    Synonyme
    elovl4 antikoerper, MGC122553 antikoerper, ADMD antikoerper, CT118 antikoerper, ISQMR antikoerper, STGD2 antikoerper, STGD3 antikoerper, elongation of very long chain fatty acids protein 4 antikoerper, ELOVL fatty acid elongase 4 antikoerper, elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 antikoerper, CpipJ_CPIJ002114 antikoerper, CpipJ_CPIJ003687 antikoerper, CpipJ_CPIJ011025 antikoerper, CpipJ_CPIJ013819 antikoerper, ELOVL4 antikoerper, elovl4 antikoerper, Elovl4 antikoerper
    Hintergrund
    Mutations in elongation of very long-chain fatty acid-4 (ELOVL4) are associated with autosomal dominant Stargardt-like macular degeneration (STGD3), with a five base-pair (5 bp) deletion mutation resulting in the loss of 51 carboxy-terminal amino acids and truncation of the protein. Elovl4 is expressed in the retina and only a limited number of mammalian other tissues, including skin, with unknown function. In a mouse model with the 5-bp deletion in the Elovl4 gene, mice in the heterozygous state (Elovl4(+/del)) demonstrate progressive photoreceptor degeneration. Homozygous mice (Elovl4(del/del)) display scaly, wrinkled skin, have severely compromised epidermal permeability barrier function, and die within a few hours after birth. Lipid analyses of epidermis from Elovl4(del/del) mice show a decrease in very long-chain fatty acids (VLFAs) in both the ceramide/glucosylceramide and the free fatty-acid fractions. ELOVL4 is required for generating VLFA critical for epidermal barrier function.Synonyms: 3-keto acyl-CoA synthase ELOVL4, Elongation of very long chain fatty acids protein 4
    Gen-ID
    6785
    NCBI Accession
    NP_073563
    UniProt
    Q9GZR5
Sie sind hier:
Kundenservice